StoxGujarat Kidney And Super Speciality Limited
NSE: GKSL · Unclassified
Ask the data
Instant answers about Gujarat Kidney And Super Speciality Limited — computed from its filings, no language modelPrice & valuation
split & bonus adjusted · pick a metric and rangeAnnual performance
annual · ₹ crore · line = operating margin| FY26 | |
|---|---|
| Revenue | 82.0 |
| EBITDA | 26.9 |
| Operating margin | 32.8% |
| Interest | 1.9 |
| Depreciation | 4.7 |
| Profit before tax | 21.2 |
| Tax | 4.4 |
| Net profit | 15.5 |
| EPS ₹ | 2.49 |
| Operating cash flow | -3.9 |
| Capex | 10.8 |
| Dividend paid | 0.0 |
| Total assets | 297.6 |
| Equity | 252.5 |
Quarterly performance
last 5 quarters · ₹ crore| SEP '25 | DEC '25 | MAR '26 | JUN '26 | SEP '26 | |
|---|---|---|---|---|---|
| Revenue | 12.9 | 23.2 | 30.6 | 34.3 | 38.1 |
| Operating profit | 5.1 | 6.9 | 6.3 | 8.4 | 10.2 |
| Operating margin | 39.6% | 29.6% | 20.6% | 24.4% | 26.8% |
| Other income | 0.1 | 0.1 | 0.7 | 0.7 | 0.6 |
| Interest | 0.3 | 0.6 | 0.8 | 0.7 | 0.7 |
| Depreciation | 0.9 | 1.3 | 1.5 | 1.4 | 1.5 |
| Profit before tax | 4.0 | 5.0 | 4.7 | 7.0 | 8.6 |
| Tax | 1.1 | 1.3 | -0.1 | 1.6 | 2.0 |
| Net profit | 2.7 | 2.9 | 5.0 | 5.2 | 5.8 |
| EPS ₹ | 0.52 | 0.52 | 0.81 | 0.66 | 0.74 |
| Revenue YoY | — | — | — | — | 194.6% |
| Profit YoY | — | — | — | — | 118.7% |
Returns & margins
trailing-twelve-month, per quarter| JUN '26 | SEP '26 | |
|---|---|---|
| ROE | 6.3% | 7.2% |
| ROCE | 8.6% | 10.0% |
| Net margin | 15.7% | 15.1% |
| EBITDA margin | 26.4% | 25.2% |
| Debt / equity | 0.06 | 0.07 |
| Interest coverage | 9.78 | 10.23 |
| Asset turnover | 0.34 | 0.39 |
Balance sheet
equity vs borrowings over time · ₹ crore| SEP '25 | MAR '26 | SEP '26 | |
|---|---|---|---|
| Share capital | 11.4 | 15.8 | 15.8 |
| Other equity / reserves | 22.1 | 236.7 | 247.9 |
| Total equity | 33.5 | 252.5 | 263.6 |
| Borrowings | 15.4 | 15.7 | 17.3 |
| Current liabilities | 33.5 | 27.8 | 41.3 |
| Non-current liabilities | 7.0 | 15.1 | 15.6 |
| Total assets | 75.7 | 297.6 | 326.7 |
| Property, plant & equipment | 18.6 | 27.0 | 31.9 |
| Capital work-in-progress | 0.0 | — | — |
| Investments | 0.0 | 0.0 | 12.0 |
| Inventories | 0.8 | 2.1 | 3.0 |
| Receivables | 22.9 | 38.6 | 42.4 |
| Cash & equivalents | 3.5 | 13.3 | 12.1 |
Cash flow
annual · ₹ crore · line = free cash flow| FY26 | |
|---|---|
| Cash from operations | -3.9 |
| Cash from investing | -213.8 |
| Cash from financing | 228.4 |
| Capex | 10.8 |
| Free cash flow | -14.7 |
| Dividends paid | 0.0 |
Where the assets sit
Sep '26 · ₹ crorePeer comparison
largest in Unclassified · this company in bold| Company | Market cap ₹cr | Price | P/E | P/B | ROE |
|---|---|---|---|---|---|
| Avantel Limited | 36,86,04,549 | 138.69 | — | 1059360.68 | 0.0% |
| Ducol Organics And Colours Limited | 19,55,275 | 120.00 | — | 20089.13 | 0.0% |
| Jio Platforms Limited | 12,57,181 | 1,406.40 | — | 3.57 | — |
| SBI Funds Management Limited | 1,01,750 | 499.55 | — | — | — |
| Tamilnadu Telecommunication Limited | 91,314 | 9.93 | — | — | — |
| Manipal Health Enterprises Limited | 76,294 | 646.70 | — | — | — |
| INDO-MIM Limited | 59,042 | 1,219.50 | — | — | — |
| AvenuesAI Limited | 45,138 | 129.25 | 153.6 | 9.51 | 6.2% |
| Dhoot Transmission Limited | 32,761 | 1,601.60 | — | 8.11 | — |
| 3M India Limited | 31,071 | 27,570.00 | 53.8 | 17.57 | 32.7% |
| Gujarat Kidney And Super Speciality Limited | 1,229 | 155.92 | 64.7 | 4.66 | 7.2% |
StoxGud checklist: Neutral setup · 5/10
- Price above 50-day average
- Price above 200-day average
- 50-day average above 200-day (uptrend)
- RSI in healthy 40–70 zone
- Positive 1-year return
- Return on equity above 15%
- Debt to equity below 1
- Revenue growing year on year
- Net profit margin above 10%
- P/E below industry median
A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.
Returns & technicals
FAQs
What is the share price of Gujarat Kidney And Super Speciality Limited?
Gujarat Kidney And Super Speciality Limited (GKSL) closed at ₹155.92 on NSE on 06 Nov 2026.
What is the market cap of Gujarat Kidney And Super Speciality Limited?
₹1,229 crore at the latest close.
What is the P/E ratio of Gujarat Kidney And Super Speciality Limited?
64.7, on trailing-twelve-month earnings from its filings.
How fast is Gujarat Kidney And Super Speciality Limited growing?
Gujarat Kidney And Super Speciality Limited: Latest-quarter revenue is up 194.6% year on year, profit up 118.7%.
How profitable is Gujarat Kidney And Super Speciality Limited?
On a trailing-twelve-month basis return on equity is 7.2%, return on capital employed 10.0%, operating margin 25.2%, net margin 15.1%.
How much debt does Gujarat Kidney And Super Speciality Limited have?
Gujarat Kidney And Super Speciality Limited is lightly geared: debt to equity is 0.07 with borrowings of ₹17 cr against cash of ₹12 cr (balance sheet of 2026-09-30). Operating profit covers interest 10.2 times.
Financials parsed from Gujarat Kidney And Super Speciality Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from SEP '25, annual from FY26, balance sheet from Sep '25. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.